Skip to content
TrustList
Frontier IP Group plc cover

About Frontier IP Group plc

Final results: portfolio equity value up 24 per cent to £39.7 million

A landmark year saw our first partial exit after Exscientia listed on Nasdaq and the rest of the portfolio performed strongly Pre-tax profits rose to £10 9 million

Alusid extends product range in collaboration with world leader Imerys

Alusid has successfully collaborated with world-leading specialty minerals group Imerys to create floor tiles after becoming one of two winners in a global competition

Celerum appoints Chief Executive Officer

Celerum has appointed David Gladding, who has more than 30 years’ experience at senior levels in software and IT services companies as CEO

DARPA-funded TVG project develops transmissible Lassa fever vaccine candidate

Trial of transmissible Lassa fever candidate vaccine for use in rats to reduce its the threat to humans as part of project funded by the US Defense Advanced Research Projects Agency

Our portfolio companies are involved in developing a wide range of technologies based on cutting-edge intellectual property to meet the needs and demands of the world

AquaInSilico is developing software tools to optimise wastewater treatment across many different industries, including municipal waste water treatment plants, oil groups, brewers, pulp, paper and steel makers, food processing and waste recovery businesses

Categories & features

Ask TrustList to introduce you to Frontier IP Group plc

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of Frontier IP Group plc

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Frontier IP Group plc.

Frontier IP Group plc alternatives

Similar listings buyers compare against this one.